PAHC stock is under investors' radar due to its booming animal health sales, new product lines and rising vaccine demand.

I remain positive on Phibro's long-term prospects and would look to buy on dips, as structural improvements appear ...

Phibro (PAHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Phibro Animal Health (PAHC) is on the list of such stocks currently recommended by our proprietary system. In addition to a favorable Growth Score, it carries a top Zacks Rank.

Global Animal Health Market is expected to grow at a rate of 8-9% by 2029. Growing awareness of animal health products, ...

But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look. The best way to find great value stocks is to pair a strong Zacks Rank ...